Here's the live share price of Akums Drugs & Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Akums Drugs & Pharmaceuticals has declined 10.35% CAGR. Over the past year, the corresponding return has been -45.18%.
Akums Drugs & Pharmaceuticals’s current P/E of 21.25x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Akums Drugs & Pharmaceuticals | 0.07 | 2.07 | -10.88 | -10.99 | -45.18 | -16.65 | -10.35 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Akums Drugs & Pharmaceuticals has declined 45.18% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Akums Drugs & Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 463.2 | 464 |
| 10 | 462.89 | 462.55 |
| 20 | 454.46 | 461.04 |
| 50 | 463.56 | 469.99 |
| 100 | 504.89 | 492.07 |
| 200 | 517.63 | 551.3 |
In the latest quarter, Akums Drugs & Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 9.28%, FII holding fell to 2.27%, and public shareholding moved up to 10.46% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 25,33,367 | 1.44 | 111.84 | |
| 22,30,054 | 0.74 | 98.45 | |
| 15,15,264 | 0.82 | 66.89 | |
| 6,00,000 | 1.21 | 26.49 | |
| 2,57,352 | 0.88 | 11.36 | |
| 95,000 | 1.18 | 4.19 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 20, 2025, 7:02 PM IST | Akums Drugs & Pharma - Incorporation Of Wholly Owned Subsidiary In Malta |
| Oct 14, 2025, 6:00 AM IST | Akums Drugs & Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 14, 2025, 3:10 AM IST | Akums Drugs & Pharma - Incorporation Of Joint Venture Company |
| Oct 10, 2025, 9:53 PM IST | Akums Drugs & Pharma - Resignation Of Senior Management Personnel |
| Sep 17, 2025, 7:02 PM IST | Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Akums Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 19/04/2004 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L24239DL2004PLC125888 and registration number is 25888. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1311.78 Cr. and Equity Capital is Rs. 30.62 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Akums Drugs & Pharmaceuticals is ₹461.10 as on Oct 31, 2025.
The Akums Drugs & Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Akums Drugs & Pharmaceuticals is ₹7,257.44 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Akums Drugs & Pharmaceuticals are ₹465.60 and ₹459.00.
The 52-week high/low is the highest and lowest price at which Akums Drugs & Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Akums Drugs & Pharmaceuticals is ₹892.00 and 52-week low of Akums Drugs & Pharmaceuticals is ₹407.40 as on Oct 31, 2025.
The Akums Drugs & Pharmaceuticals has shown returns of -1.1% over the past day, 2.07% for the past month, -10.88% over 3 months, -45.18% over 1 year, -16.65% across 3 years, and -10.35% over 5 years.
P/E ratio of and PB ratio of Akums Drugs & Pharmaceuticals are 21.25 and 2.38 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.